[PDF][PDF] COVID-19 infection: The prospects of pharmacotherapy
SM Patil, VC Kumari, PS Shirahatti… - … Journal of Health & …, 2020 - researchgate.net
The disastrous outbreak of coronavirus disease 2019 (COVID‑19) has triggered the
investigation of several therapeutic options following the redundancy of specific drugs …
investigation of several therapeutic options following the redundancy of specific drugs …
[HTML][HTML] Pharmacotherapy of COVID-19: A perspective of pathogenicity and life cycle
SM Patil, CK VB, PS Shirahatti, S Sa… - Biomedical and …, 2020 - biomedpharmajournal.org
The world has witnessed COVID-19 or SARS-CoV-2 as one of the most hazardous viral
outbreak in the history of mankind. Since its emergence in December 2019, it has been …
outbreak in the history of mankind. Since its emergence in December 2019, it has been …
The chronicle of COVID-19 and possible strategies to curb the pandemic
COVID-19, a type of infection that emerged in Wuhan, has become a pandemic affecting
people worldwide and is rapidly spreading and evolving. Day by day, the confirmed cases …
people worldwide and is rapidly spreading and evolving. Day by day, the confirmed cases …
[HTML][HTML] A review on coronavirus disease and potentially active drugs targeting coronavirus
T Verma, M Sinha, B Nitin, SR Yadav… - Biomedical and …, 2021 - journals.lww.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus with single
positive-strand RNA, having glycoproteins projection on envelopes so reveals a halo-like …
positive-strand RNA, having glycoproteins projection on envelopes so reveals a halo-like …
[HTML][HTML] Available drug therapies on COVID-19 and its side effects: An overview
N Malik, UP Dhuldhaj - Cellular, Molecular and Biomedical …, 2023 - cmbr-journal.com
The sudden outbreak of coronavirus turned into a pandemic and resulted in huge socio-
economic and human losses becoming a public health emergency. It took just 3-4 months to …
economic and human losses becoming a public health emergency. It took just 3-4 months to …
COVID-19 Pandemic: current Challenges and future Perspectives
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lead to the current
pandemic of coronavirus disease 2019 (COVID-19) and more than one hundred million …
pandemic of coronavirus disease 2019 (COVID-19) and more than one hundred million …
COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As
there is no defensive immunity in humans and a virus can overcome inborn immune …
there is no defensive immunity in humans and a virus can overcome inborn immune …
[HTML][HTML] Hot Topic Commentary on COVID-19
AN Kong, ATY Lau, L Brunetti - Current pharmacology reports, 2020 - Springer
The recent pandemic outbreak of COVID-19 (severe acute respiratory syndrome coronavirus
2; SARS-CoV-2) worldwide caught the health care systems in every country around the …
2; SARS-CoV-2) worldwide caught the health care systems in every country around the …
Emerging treatment approaches for COVID-19 infection: a critical review
In the present scenario, the SARS-CoV-2 virus has imposed enormous damage on human
survival and the global financial system. It has been estimated that around 111 million …
survival and the global financial system. It has been estimated that around 111 million …
COVID-19: virology, pathogenesis and potential therapeutics
Nowadays, the coronavirus epidemic represents a major threat to the human being,
represented by great numbers of deaths and wide world life disrupt. COVID-19 virus, is not …
represented by great numbers of deaths and wide world life disrupt. COVID-19 virus, is not …